Equities

Guanze Medical Information Industry (Holding) Co Ltd

Guanze Medical Information Industry (Holding) Co Ltd

Actions
  • Price (HKD)0.80
  • Today's Change0.06 / 8.11%
  • Shares traded260.00k
  • 1 Year change+138.81%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 08:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Guanze Medical Information Industry (Holding) Co Ltd is an investment holding company principally engaged in providing medical imaging film products and medical imaging cloud services. The Company, together with its subsidiaries, is mainly engaged in the sales of medical imaging films procured from international brands and medical imaging films under its own Guanze Huiyi brand to hospitals and healthcare institutions. The Company's provided medical imaging films type primarily include medical dry laser films, thermal films and medical printing films. The Company’s medical imaging cloud services mainly include digital medical imaging cloud storage platform, digital medical image platform; regional imaging diagrams platform and PACS system. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)168.49m
  • Net income in HKD29.76m
  • Incorporated2020
  • Employees56.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.